Tag: Erythropoiesis stimulating agents

Anemia of inflammation is the second most common cause of anemia worldwide, often linked to underlying chronic infections, autoimmune diseases, or cancer. Effectively learning how to treat anemia from inflammation requires a multi-pronged approach that targets both the inflammation and its impact on the body's iron regulation and red blood cell production.

According to the American Cancer Society, anemia, or a low red blood cell count, is a very common side effect of chemotherapy, impacting a large number of patients. Knowing how to increase blood during chemotherapy is crucial for managing fatigue and other symptoms that can significantly impact daily life and treatment tolerability.